CFO

David Dautel

David has over 35 years of experience in finance and accounting, ranging from start-ups, to non-profit organizations and large pharmaceutical companies, in both the public & private sectors and for domestic as well as multi-national organizations, including his 10+ years of professional consulting.

David’s focus is on effective cost cutting, cash flow management, analyzing the company’s financial position, financial reporting, budgeting, forecasting and developing internal controls; helping to successfully guide companies to operate within their given budgets; while steering them to or toward future financial success.

Working alongside Anthony Rotunno, David played an integral role in the streamlining and manufacturing cost reduction for the commercial manufacture of Dendreon’s Provenge® immunotherapy treatment.

David has close family members who have died from cancer and who are currently fighting cancer. What inspires David is to be able to do what he loves in his career and continue to contribute to the greater common goal of fighting life-threatening diseases, such as cancer.